Tweetovi

Blokirali ste korisnika/cu @FPrimeCapital

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @FPrimeCapital

  1. proslijedio/la je Tweet
    4. velj

    The lab-software stack is changing. Here's how

    Poništi
  2. 4. velj

    Thrilled to announce our investment in ! Leveraging AI to help biomedical scientists cut time and costs from research. 👇

    Poništi
  3. 30. sij

    Our tech team did an end-of-year reflection on the current state of venture. We are sharing it with our broader community in the hope that someone will find it informative, interesting or at least entertaining.

    Poništi
  4. 29. sij

    Today’s highlights a pressing issue – the gender imbalance in the biotech industry. F-Prime is committed to supporting efforts to increase the number of women in leadership positions.

    Poništi
  5. proslijedio/la je Tweet
    22. sij

    So excited to host Jeremy Allaire at our next Founders Diaries. A true rock star founder who has redefined multiple industries Macromedia

    Poništi
  6. 17. sij

    Excited to announce our investment in with our sister fund .

    Poništi
  7. 15. sij

    Congratulations to portfolio company for successfully raising $21M Series B to roll out digital diabetes treatment across Europe

    Poništi
  8. 14. sij

    Awesome news for (and the team of acquired ) on their impressive acquisition by . Huge step forward for FinTech infrastructure!

    Poništi
  9. 14. sij

    Yesterday was a very big day for our portfolio company . We’re proud to support you!

    Poništi
  10. 13. sij

    Very proud of our portfolio company for reaching this important milestone! Congrats to the team.

    Poništi
  11. 9. sij

    Don’t miss the latest news from , in – the company’s drug candidate for a rare blood condition outperformed a blockbuster drug in a clinical trial comparing the two:

    Poništi
  12. 20. pro 2019.

    Sending our congrats to the fantastic team at Turnstone Biologics on their new strategic collaboration with Takeda to develop multiple products using their viral immunotherapy platform.

    Poništi
  13. 19. pro 2019.

    Thrilled to share our portfolio company , announced a new partnership with PhysicianOne Urgent Care to provide more convenient options for to patients. Congrats to the team! Learn more:

    Poništi
  14. proslijedio/la je Tweet
    19. pro 2019.

    Great write up in from today on how will be crucial in enabling the next wave of life science breakthroughs and what and are building to unlock the potential of big in

    Poništi
  15. proslijedio/la je Tweet
    19. pro 2019.

    Great write up in from today on how will be crucial in enabling the next wave of life science breakthroughs and what is building to unlock the potential of big in

    Poništi
  16. proslijedio/la je Tweet
    17. pro 2019.
    Poništi
  17. proslijedio/la je Tweet
    13. pro 2019.

    I can check an item off the bucket list. has promoted an company product. Congrats for making Ellen’s list, presented by no less!

    Poništi
  18. proslijedio/la je Tweet
    7. pro 2019.
    Prikaži ovu nit
    Poništi
  19. 6. pro 2019.

    Innovent Biologics hit yet another significant milestone this week with the dosing of the first patient in its Phase 1 clinical trial of its anti-tumor therapy IBI110:

    Poništi
  20. 4. pro 2019.

    Congratulations to the impressive team at portfolio company . The has granted RMAT designation to ADP‑A2M4 for the treatment of synovial sarcoma.

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·